Financial Performance - The company reported first quarter revenue of $174.7 million, a 45.6% increase year-over-year, with a full quarter contribution from Concorde of $59.3 million, which increased by $44.9 million compared to the prior year [23][22][26] - Adjusted EBITDA for the first quarter was $24.5 million, reflecting measurable year-over-year growth due to improved operating leverage and cost efficiencies [35][22] - Consolidated net income for the first quarter was $10.4 million, or $0.17 per diluted share [35] Business Line Performance - The UTI division saw a 9.3% year-over-year growth, while student starts in the UTI division increased by 17.2% year-over-year [23][34] - The company launched 14 new programs last year, with strong demand resulting in almost 400 combined student starts across these programs over the last two quarters [18][21] - Concorde's core starts grew by 14.4% on a pro forma basis, with total starts growing by 12.5% [61] Market Performance - The company anticipates generating annual revenue between $710 million and $720 million, with adjusted EBITDA expected to be between $100 million and $103 million [21][65] - The company expects to maintain a strong demand for its healthcare programs, particularly in dental hygiene, which has shown rapid enrollment growth [29][46] Company Strategy and Industry Competition - The company is focused on growth and diversification, with plans to optimize cost structures and drive increased yield from past investments [68][66] - The company is actively managing its revolver draw to minimize interest expenses while maintaining a target of approximately $30 million in capital expenditures for the year [2][8] - The company is exploring additional program expansions and potential M&A opportunities, particularly in the healthcare sector [112][91] Management Commentary on Operating Environment and Future Outlook - Management expressed confidence in the trajectory of student starts and raised full-year revenue and profitability guidance for fiscal 2024 [32][38] - The company noted that the majority of cash flow is generated in the fourth quarter, with expectations for strong unadjusted free cash flow for the fiscal year [8][38] - Management highlighted the importance of maintaining strong relationships with industry partners to enhance student employment outcomes [110] Other Important Information - The company successfully converted its Series A preferred stock into common stock, increasing total common shares outstanding by 19.3 million shares [36] - Total available liquidity at the end of the quarter was $143.6 million, including a $90 million drawdown of the revolving credit facility [64] Q&A Session Summary Question: What is working on the marketing side? - The company has significantly increased its presence in high schools, with representatives conducting multiple career presentations weekly, generating strong interest [69] Question: How is the integration of Concorde progressing? - The integration is moving into more operational aspects, including payroll and benefits, with a focus on optimizing financial systems [127] Question: What are the expectations for revenue and EBITDA growth? - The company expects strong growth in the first half of the year, with a moderation in the second half, but remains confident in achieving its full-year guidance [125][66] Question: What is the current status of the composite score? - The company is comfortably above the 1.5 threshold for the composite score, which is crucial for compliance with the Department of Education [118] Question: What are the priorities for capital allocation? - The company prioritizes growth initiatives and program expansions, while also considering M&A opportunities in the healthcare sector [86][112]
Universal Technical Institute(UTI) - 2024 Q1 - Earnings Call Transcript